1-20 of 60
Mario Annunziata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Follow-up from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): An End of Study Treatment (EOS Tx) Update, Including Results from Switch Population

Michael Mauro, Yosuke Minami, Andreas Hochhaus, Elza Lomaia, Sergei Voloshin, Anna Turkina, Dong-Wook Kim, Jane F Apperley, Jorge Cortes, Andre N.R. Abdo, Laura Maria Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saussele, Mario Annunziata, Timothy P Hughes, Naeem A. Chaudhri, Lynette C.Y. Chee, Valentín García Gutiérrez, Koji Sasaki, Carla Maria Boquimpani De Moura Freitas, Shruti Kapoor, Noemi Espurz, Vishal Dhamal, Delphine Rea
Journal: Blood
Blood (2023) 142 (Supplement 1): 4536.
https://doi.org/10.1182/blood-2023-186854
Published: 2023
Journal Articles

Use of Ponatinib Alone or Combined with Other Therapies in Relapsed/Refractory Ph-like Acute Lymphoblastic Leukemia. a Campus ALL Real-Life Study

Monia Lunghi, Francesca Kaiser, Deborah Cardinali, Claudia Basilico, Marzia Defina, Sara Mastaglio, Lazzarotto Davide, Prassede Salutari, Matteo Piccini, Valeria Cardinali, Antonio Pierini, Nicola Fracchiolla, Federica Di Biase, Mario Annunziata, Mariangela Di Trani, Felicetto Ferrara, Giovanni Pizzolo, Robin Foà, Sabina Chiaretti
Journal: Blood
Blood (2023) 142 (Supplement 1): 1507.
https://doi.org/10.1182/blood-2023-182091
Published: 2023
Journal Articles

On the Children Side. Overview of 194 Outcomes from Gimema Registry of Conception/Pregnancy in Chronic Myeloid Leukemia (CML)

Elisabetta Abruzzese, Elena Chiara, Fausto Castagnetti, Mario Annunziata, Carlo Gambacorti-Passerini, Luigiana Luciano, Antonella Russo Rossi, Alessandra Iurlo, Isabella Capodanno, Valentina Giai, Mariella D'Adda, Fabio Stagno, Antonella Gozzini, Mario Tiribelli, Federica Sorà, Sara Galimberti, Monica Bocchia, Germana Beltrami, Carmen Fava, Maria Cristina Miggiano, Massimo Breccia, Marco Cerrano, Anna Rita Scortechini, Olga Mulas, Clementina Caracciolo, Stefana Impera, Claudio Fozza, Alessandra Malato, Lucia Mastrullo, Marzia Salvucci, Monia Lunghi, Filippo Gherlinzoni, Paolo De Fabritiis, Paola Fazi, Sonia Maria Orlando, Alfonso Piciocchi, Fabrizio Pane
Journal: Blood
Blood (2023) 142 (Supplement 1): 3178.
https://doi.org/10.1182/blood-2023-188305
Published: 2023
Journal Articles

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Therapy of Acute Myeloid Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata, Benedetta Cambò, Anna Lina Piccioni, Vincenzo Federico, Gianluca Cristiano, Elisabetta Lugli, Lorenzo Rizzo, Michelina Santopietro, Carla Mazzone, Massimiliano Bonifacio, Raffaele Palmieri, Antonella Poloni, Annalisa Biagi, Gianni Binotto, Marzia Delfina, Mario Annunziata, Alfredo Molteni, Monica Piedimonte, Ida Carmosino, Ambra Di Veroli, Pasquale Niscola, Marta Riva, Isabella Capodanno, Antonio Curti, Nicola Di Rienzo, Susanna Fenu, Monica Crugnola
Journal: Blood
Blood (2023) 142 (Supplement 1): 6497.
https://doi.org/10.1182/blood-2023-186085
Published: 2023
Journal Articles

Efficacy of Frontline Treatment with Initial Low-Dose Tyrosine-Kinase Inhibitors in Elderly Patients with Chronic Myeloid Leukemia: A “Campus CML” Study

Cristina Bucelli, Isabella Capodanno, Maria Cristina Miggiano, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Mario Annunziata, Federica SORA, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Imma Attolico, Gianni Binotto, Elena Crisa', Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Rosaria Sancetta, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Alessandra Iurlo, Mario Tiribelli, Roberto Latagliata
Journal: Blood
Blood (2023) 142 (Supplement 1): 3176.
https://doi.org/10.1182/blood-2023-186406
Published: 2023
Journal Articles

Association of Hypometilating Agents (HMA) + Venetoclax (VEN) in the Treatment of Myeloproliferative Neoplasms in Blastic Phase (MPN-BP) and Acute Leukemias Evolved from Myelodysplastic Syndromes (AML-MDS) Already Treated with Azacytidine

Roberto Latagliata, Gianluca Cristiano, Dorela Lama, Susanna Fenu, Lorenzo Rizzo, Benedetta Cambò, Simone Zoletto, Francesca Spirito, Fabrizio Cavalca, Daniele Cattaneo, Natalia Cenfra, Giulia De Luca, Beatrice Esposito Vangone, Ambra Di Veroli, Raffaele Palmieri, Mario Annunziata, Olga Mulas, Elisabetta Abruzzese, Alfredo Molteni, Monica Piedimonte, Ida Carmosino, Prassede Salutari, Annalisa Biagi, Monica Bocchia, Michelina Santopietro, Gianni Binotto, Alessandra Iurlo, Monica Crugnola, Marta Riva, Anna Lina Piccioni, Elena Maria Elli, Antonio Curti, Antonella Poloni
Journal: Blood
Blood (2022) 140 (Supplement 1): 6176–6178.
https://doi.org/10.1182/blood-2022-167334
Published: 2022
Journal Articles

Dosing Pattern of Ruxolitinib (RUX) in Patients with Myelofibrosis (MF) in Italy: Results from a Prospective Observational Study (ROMEI)

Massimo Breccia, Paola Guglielmelli, Francesco Mendicino, Alessandra Malato, Giuseppe A. Palumbo, Carmine Selleri, Daniela Cilloni, Patrizio Mazza, Sergio Siragusa, Elisabetta Abruzzese, Maurizio Martelli, Giulia Benevolo, Erminia Rinaldi, Monica Crugnola, Serena Rupoli, Vincenzo Pavone, Massimiliano Bonifacio, Fabrizio Pane, Giuseppe Carli, Maria Langella, Marta Bruno Ventre, Elena Maria Elli, Stefana Impera, Anna Marina Liberati, Nicola Di Renzo, Bruno Martino, Paolo Sportoletti, Mario Tiribelli, Gianni Binotto, Mario Annunziata, Mauro Di Ianni, Giorgio La Nasa, Antonietta Pia Falcone, Rossana Leanza, Antonio Volpe, Filippo Gherlinzoni, Valerio De Stefano, Daniele Vallisa, Sabrina Leonetti Crescenzi, Francesco Cavazzini, Alessandra Ricco, Carmela Barberio, Alessandra Misto, Francesco Passamonti, Francesca Palandri
Journal: Blood
Blood (2022) 140 (Supplement 1): 9688–9690.
https://doi.org/10.1182/blood-2022-157914
Published: 2022
Journal Articles

Host immune system modulation in Ph + acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Maria Cristina Puzzolo, Giulia Radice, Nadia Peragine, Maria Stefania de Propris, Paola Mariglia, Marco Vignetti, Antonella Vitale, Renato Bassan, Mario Annunziata, Gianluca Gaidano, Alessandro Rambaldi, Sabina Chiaretti, Anna Guarini, Robin Foà
Journal: Blood
Blood (2021) 138 (22): 2290–2293.
https://doi.org/10.1182/blood.2021011822
Published: 2021
Includes: Supplemental data
Journal Articles

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

Clinical Trials & Observations
Delphine Réa, Michael J. Mauro, Carla Boquimpani, Yosuke Minami, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Jane F. Apperley, Andre Abdo, Laura Maria Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saussele, Mario Annunziata, Timothy P. Hughes, Naeem Chaudhri, Koji Sasaki, Lynette Chee, Valentin García-Gutiérrez, Jorge E. Cortes, Paola Aimone, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Andreas Hochhaus
Journal: Blood
Blood (2021) 138 (21): 2031–2041.
https://doi.org/10.1182/blood.2020009984
Published: 2021
Includes: Supplemental data
Journal Articles

ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report

Sabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, Mario Annunziata, Anna Candoni, Cerrano Marco, Michele Cedrone, Maria Ciccone, Patrizia Chiusolo, Antonio Curti, Michelina Dargenio, Marzia Defina, Mario Delia, Maria Ilaria Del Principe, Mauro Endri, Carmen Fava, Fabio Forghieri, Alessandro Fiorentini, Fabio Giglio, Francesco Grimaldi, Fabio Guolo, Michela Lamanda, Monia Lunghi, Federico Lussana, Valentina Mancini, Carla Mazzone, Antonino Mulè, Crescenza Pasciolla, Matteo Piccini, Giovanna Rege Cambrin, Prassede Salutari, Lidia Santoro, Anna Maria Scattolin, Mariarita Sciumè, Elisabetta Todisco, Felicetto Ferrara, Giovanni Pizzolo, Robin Foà
Journal: Blood
Blood (2021) 138 (Supplement 1): 216.
https://doi.org/10.1182/blood-2021-150958
Published: 2021
Journal Articles

Efficacy and Safety Results from Ascembl, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, Vs Bosutinib in Patients with Chronic Myeloid Leukemia in Chronic Phase after ≥2 Prior Tyrosine Kinase Inhibitors: Update after 48 Weeks

Michael J. Mauro, Yosuke Minami, Delphine Rea, Andreas Hochhaus, Elza Lomaia, Sergey Voloshin, Anna G. Turkina, Dong-Wook Kim, Jane F Apperley, Jorge E. Cortes, Andre N.R. Abdo, Laura Fogliatto, Dennis Dong Hwan Kim, Philipp D le Coutre, Susanne Saussele, Mario Annunziata, Timothy P. Hughes, Naeem A. Chaudhri, Lynette C.Y. Chee, Valentín Garcia Gutierrez, Koji Sasaki, Shruti Kapoor, Alex Allepuz, Sarah Quenet, Véronique Bédoucha, Carla Boquimpani
Journal: Blood
Blood (2021) 138 (Supplement 1): 310.
https://doi.org/10.1182/blood-2021-152561
Published: 2021
Journal Articles

Blinatumomab and Inotuzumab for the Treatment of Multiply Relapsed Acute Lymphoblastic Leukemia: A Real-Life Campus ALL Study

Mariarita Sciumè, Cristina Papayannidis, Antonio Curti, Antonella Vitale, Sabina Chiaretti, Mario Annunziata, Fabio Giglio, Prassede Salutari, Fabio Forghieri, Davide Lazzarotto, Monia Lunghi, Annalisa Imovilli, Barbara Scappini, Massimiliano Bonifacio, Michelina Dargenio, Carmela Gurrieri, Elisabetta Todisco, Marzia Defina, Maria Ilaria Del Principe, Patrizia Zappasodi, Marco Cerrano, Lidia Santoro, Enrico Barozzi, Pasquale De Roberto, Elisa Buzzatti, Chiara Sartor, Luca Baldini, Robin Foa, Nicola S Fracchiolla
Journal: Blood
Blood (2021) 138 (Supplement 1): 3408.
https://doi.org/10.1182/blood-2021-147325
Published: 2021
Journal Articles

Multicenter, Prospective and Retrospective Observational Cohort Study of Ponatinib in Patients with CML in Italy: Primary Analysis of the Oiti Trial

Massimo Breccia, Luigia Luciano, Mario Annunziata, Imma Attolico, Alessandra Malato, Elisabetta Abruzzese, Massimiliano Bonifacio, Anna Rita Scortechini, Nicola Cascavilla, Nicola Di Renzo, Stefana Impera, Monia Lunghi, Marco Santoro, Fausto Castagnetti, Alessandro Maggi, Valeria Sargentini, Alfonso Piciocchi, Claudia Galimberti, Alessandra Iurlo
Journal: Blood
Blood (2021) 138 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2021-146139
Published: 2021
Journal Articles

Choice of Frontline Tyrosine-Kinase Inhibitor in Very Elderly Patients with Chronic Myeloid Leukemia: A "Campus CML" Study

Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Francesco Cavazzini, Sabrina Leonetti Crescenzi, Sabina Russo, Gioia Colafigli, Mario Annunziata, Federica Sora, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Rikard Mullai, Imma Attolico, Gianni Binotto, Elena Crisà, Alessandra Iurlo, Paolo Sportoletti, Ambra Di Veroli, Anna Rita Scortechini, Annapaola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Rosaria Sancetta, Pamela Murgano, Davide Rapezzi, Debora Luzi, Monica Bocchia, Carmen Fava, Alessandra Malato, Jolanda Donatella Vincelli, Elisabetta Abruzzese, Giuseppe Nicola Saglio, Giorgina Specchia, Massimo Breccia, Mario Tiribelli
Journal: Blood
Blood (2021) 138 (Supplement 1): 3617.
https://doi.org/10.1182/blood-2021-151538
Published: 2021
Journal Articles

Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs

Andreas Hochhaus, MD, Carla Boquimpani, MD, Delphine Rea, MDPhD, Yosuke Minami, MDPhD, Elza Lomaia, MD PhD, Sergey Voloshin, MD PhD, Anna G. Turkina, Prof., MD, Dong-Wook Kim, MD, Jane Apperley, FRCP, FRCPath, MB, Jorge E. Cortes, MD, Andre Abdo, MD, Laura Maria Fogliatto, MD PhD, Dennis Dong Hwan Kim, MD PhD, Philipp D le Coutre, MD, Susanne Saussele, MD, Mario Annunziata, MD, Timothy P. Hughes, MDMBBS,FRACP,FRCPA, Naeem A. Chaudhri, MD, Lynette C.Y. Chee, MBBS,PhDFRACP,FRCPA, Valentín García Gutiérrez, MD PhD, Koji Sasaki, MD, Paola Aimone, MD, Alex Allepuz, MD MPH, Sarah Quenet, Véronique Bédoucha, Michael J. Mauro, MD
Journal: Blood
Blood (2020) 136 (Supplement_2): LBA-4.
https://doi.org/10.1182/blood-2020-143816
Published: 2020
Journal Articles

Sequential Treatments in Chronic Phase Chronic Myeloid Leukemia (CML) Patients without Optimal Response after Frontline Nilotinib or Dasatinib: An Italian CML Campus Study

Gabriele Gugliotta, MD PhD, Mario Annunziata, MD, Isabella Capodanno, MD, Davide Rapezzi, MD, Immacolata Attolico, MD, Iolanda Donatella Vincelli, Mario Tiribelli, MD, Alessandra Malato, MD PhD, Michele Pizzuti, MD, Vincenzo Accurso, MD, Massimiliano Bonifacio, MD, Sara Galimberti, MD PhD, Giuseppina Loglisci, MD, Elisabetta Abruzzese, MD, Monica Bocchia, Antonella Gozzini, MD, Micaela Bergamaschi, MD, Maria Cristina Miggiano, MD, Agostino Tafuri, MD, Grazia Sanpaolo, MD, Gianni Binotto, MD, Fausto Castagnetti, MDPhD, Giorgina Specchia, MD, Francesco Di Raimondo, MD, Michele Cavo, Gianantonio Rosti, MD, Robin Foà, MD, Giuseppe Saglio, MD PhD, Massimo Breccia, MD, Fabio Stagno, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-141077
Published: 2020
Journal Articles

Low Cholesterol, Low-Density Lipoprotein (LDL) and Triglycerides Plasma Levels Are Associated with Lower Risk of Arterial Occlusive Events in Chronic Myeloid Leukemia Patients Treated with Nilotinib

Giovanni Caocci, MD, Olga Mulas, Isabella Capodanno, MD, Mario Annunziata, MD, Elisabetta Abruzzese, MD, Sara Galimberti, MD PhD, Mario Tiribelli, MD, Luigiana Luciano, MD, Bruno Martino, MD, Fausto Castagnetti, MDPhD, Gianni Binotto, MD, Patrizia Pregno, Fabio Stagno, MD PhD, Monica Bocchia, Francesco Albano, Debora Luzi, Claudio Fozza, MD, Massimiliano Bonifacio, MD, Chiara Elena, MD, Antonella Gozzini, MD, Maria Pina Simula, Malgorzata Monika Trawinska, MD, Claudia Baratè, MD, Rossella Stella, MD, Fiorenza De Gregorio, MD, Gabriele Gugliotta, MD PhD, Francesca Pirillo, Daniele Cattaneo, Anna Sicuranza, PhD, Imma Attolico, MD, Luigi Scaffidi, MD, Emilia Scalzulli, MD, Alessandra Iurlo, MD PhD, Robin Foà, MD, Massimo Breccia, MD, Giorgio La Nasa, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-134496
Published: 2020
Journal Articles

Determinants of Choice of Front-Line Tyrosine Kinase Inhibitor for Chronic Phase CML: A Study from the "Registro Italiano LMC & Campus CML"

Mario Tiribelli, MD, Roberto Latagliata, Massimo Breccia, MD, Isabella Capodanno, MD, Maria Cristina Miggiano, MD, Francesco Cavazzini, MD, Sabrina Leonetti Crescenzi, MD, Sabina Russo, MD, Mario Annunziata, MD, Federica Sorà, MD, Massimiliano Bonifacio, MD, Giovanni Caocci, MD, Giuseppina Loglisci, MD, Alessandro Maggi, Gianni Binotto, MD, Elena Crisà, MD, Alessandra Iurlo, MD PhD, Anna Rita Scortechini, MD, Annapaola Leporace, MD, Rosaria Sancetta, MD, Pamela Murgano, MD, Concettina Ruggiero, MD, Giuseppe Saglio, MD PhD, Giorgina Specchia, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-135972
Published: 2020
Journal Articles

Do Not Miss Karyotyping at Chronic Myeloid Leukemia Diagnosis: An Italian Campus CML Study on the Role of Complex Variant Translocations

Massimiliano Bonifacio, MD, Chiara Elena, MD, Mariella D'Adda, MD, Luigi Scaffidi, MD, Mairi Pucci, MD, Fiorenza Aprili, Jacqueline Ferrari, MD, Alessandra Tucci, MD, Fabio Stagno, MD PhD, Anna Rita Scortechini, MD, Gianni Binotto, MD, Mario Annunziata, MD, Maria Cristina Miggiano, MD, Isabella Capodanno, MD, Sara Galimberti, MD PhD, Mario Tiribelli, MD, Emilia Giugliano, Giovanni Caocci, MD, Monica Crugnola, MD, Paola Ronchi, MD, Sabina Russo, MD, Martina Tinelli, MD, Agostino Tafuri, MD, Monica Bocchia, Alessandra Malato, MD PhD, Mauro Krampera, MD PhD, Giuseppe Lippi, MD PhD, Massimo Breccia, MD, Giuseppe Saglio, MD PhD, Antonella Gozzini, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-139826
Published: 2020
Journal Articles

Peripheral Blood CD26+ Leukemia Stem Cells Monitoring in Chronic Myeloid Leukemia Patients from Diagnosis to Response to TKIs: Interim Results of a Multicenter Prospective Study (PROSPECTIVE FLOWERS)

Monica Bocchia, Anna Sicuranza, PhD, Paola Pacelli, Alessandra Iurlo, MD PhD, Elisabetta Abruzzese, MD, Sara Galimberti, MD PhD, Patrizia Pregno, Giovanni Caocci, MD, Isabella Capodanno, MD, Monica Crugnola, MD, Antonella Gozzini, MD, Claudio Fozza, MD, Mario Annunziata, MD, Sabina Russo, Anna Marina Liberati, Olga Mulas, Daniele Cattaneo, Adele Santoni, Vincenzo Sammartano, Federico Caroni, Donatella Raspadori
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-139306
Published: 2020